++ Mycoplus ++
 
>> Development Results >> MP106, MRSA Remedy Material  
 
 
 Technical information and commercialization
Extracted from a healthful fungus little toxicity.
Strong antibiotic effect against Methicillin-resistant Staphylococcus aureus.
Innovative antibiotics that is superior to any other competing products.
Extraction and refining in progress.
Planning to perform clinical tests from 2008.
 
Test organisms
Staphylococcus aureus MRSA (Methicillin-resistant) 4 strains
Staphylococcus aureus CRSA (Ciprofloxacin-resistant) 2 strains
Enterococci VRE (Vancomycin-resistan) 2 strains